164 related articles for article (PubMed ID: 29713357)
1. TORCH (toxoplasmosis, rubella, cytomegalovirus, and herpes simplex virus) screening of small for gestational age and intrauterine growth restricted neonates: efficacy study in a single institute in Korea.
Chung MH; Shin CO; Lee J
Korean J Pediatr; 2018 Apr; 61(4):114-120. PubMed ID: 29713357
[TBL] [Abstract][Full Text] [Related]
2. Utility of routine urine CMV PCR and total serum IgM testing of small for gestational age infants: a single center review.
Espiritu MM; Bailey S; Wachtel EV; Mally PV
J Perinat Med; 2018 Jan; 46(1):81-86. PubMed ID: 28803228
[TBL] [Abstract][Full Text] [Related]
3. The Utility of Maternal TORCH Screening Due to Obstetrical Indications in Detecting Congenital Infections: A Retrospective Observational Study.
Abu Shqara R; Or S; Abu Zraki A; Rizik J; Glikman D; Rechnitzer H; Lowenstein L; Frank Wolf M
Pediatr Infect Dis J; 2024 Jan; 43(1):69-73. PubMed ID: 37725823
[TBL] [Abstract][Full Text] [Related]
4. The C in TORCH: a cost-effective alternative to screening small-for-gestational-age infants.
Wei D; Sardesai SR; Barton L
Neonatology; 2014; 106(1):24-9. PubMed ID: 24732345
[TBL] [Abstract][Full Text] [Related]
5. Yield and costs of screening growth-retarded infants for torch infections.
Khan NA; Kazzi SN
Am J Perinatol; 2000; 17(3):131-5. PubMed ID: 11012137
[TBL] [Abstract][Full Text] [Related]
6. Significance of maternal screening for toxoplasmosis, rubella, cytomegalovirus and herpes simplex virus infection in cases of fetal growth restriction.
Yamamoto R; Ishii K; Shimada M; Hayashi S; Hidaka N; Nakayama M; Mitsuda N
J Obstet Gynaecol Res; 2013 Mar; 39(3):653-7. PubMed ID: 23107457
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study.
Zhang L; Wang X; Liu M; Feng G; Zeng Y; Wang R; Xie Z
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010861. PubMed ID: 36240247
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of toxoplasmosis, rubella, cytomegalovirus, and herpes (TORCH) infections among women attending the antenatal care clinic, maternity hospital in Abha, Southwestern Saudi Arabia.
Al-Hakami AM; Paul E; Al-Abed F; Alzoani AA; Shati AA; Assiri MI; Qasim AA; Riaz F; Moosa RA; Chandramoorthy HC
Saudi Med J; 2020 Jul; 41(7):757-762. PubMed ID: 32601646
[TBL] [Abstract][Full Text] [Related]
9. Association between false-positive TORCH and antiphospholipid antibodies in healthy pregnant women.
De Carolis S; Tabacco S; Rizzo F; Perrone G; Garufi C; Botta A; Salvi S; Benedetti Panici P; Lanzone A
Lupus; 2018 Apr; 27(5):841-846. PubMed ID: 29157179
[TBL] [Abstract][Full Text] [Related]
10. Seasonal influence on TORCH infection and analysis of multi-positive samples with indirect immunofluorescence assay.
Chen L; Liu J; Shi L; Song Y; Song Y; Gao Y; Dong Y; Li L; Shen M; Zhai Y; Cao Z
J Clin Lab Anal; 2019 May; 33(4):e22828. PubMed ID: 30666721
[TBL] [Abstract][Full Text] [Related]
11. TORCH screening used appropriately in China?─three years results from a teaching hospital in northwest China.
Wang LC; Yan F; Ruan JX; Xiao Y; Yu Y
BMC Pregnancy Childbirth; 2019 Dec; 19(1):484. PubMed ID: 31818265
[TBL] [Abstract][Full Text] [Related]
12. Standardization of an in-house multiplex real-time polymerase chain reaction for the simultaneous detection of
Rajendiran P; Saravanan N; Ramamurthy M; Sankar S; Aruliah R; Nandagopal B; Sridharan G
Indian J Public Health; 2021; 65(4):369-374. PubMed ID: 34975080
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence and Determinants of ToRCH Pathogens in Pregnant Women in the Sub-Himalayan Region.
Deka S; Kalita D; Paul M; Badoni G; Mathuria YP
Cureus; 2022 Feb; 14(2):e21946. PubMed ID: 35273887
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of maternal TORCH screening in fetal growth restriction: A retrospective two-centre study.
Wade CA; Atkinson N; Holmes NE; Hui L
Aust N Z J Obstet Gynaecol; 2024 Feb; ():. PubMed ID: 38380539
[TBL] [Abstract][Full Text] [Related]
15. Utility of Neonatal Ophthalmologic Examination for Detection of Infectious Etiologies for Symmetric Intrauterine Growth Restriction.
LaMattina KC; Schwedhelm M; Lloyd M; Kushnir A; Wasserman BN
J Pediatr; 2020 Nov; 226():240-242. PubMed ID: 32629012
[TBL] [Abstract][Full Text] [Related]
16. Routine TORCH screening is not warranted in neonates with subependymal cysts.
van der Weiden S; Steggerda SJ; Te Pas AB; Vossen AC; Walther FJ; Lopriore E
Early Hum Dev; 2010 Apr; 86(4):203-7. PubMed ID: 20227842
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of torch infections and its associated poor outcome in high-risk pregnant women of Central India: Time to think for prevention strategies.
Manjunathachar HV; Singh KN; Chouksey V; Kumar R; Sharma RK; Barde PV
Indian J Med Microbiol; 2020; 38(3 & 4):379-384. PubMed ID: 33154250
[TBL] [Abstract][Full Text] [Related]
18. Is routine TORCH screening warranted in neonates with lenticulostriate vasculopathy?
de Jong EP; Lopriore E; Vossen AC; Steggerda SJ; Te Pas AB; Kroes AC; Walther FJ
Neonatology; 2010; 97(3):274-8. PubMed ID: 19887856
[TBL] [Abstract][Full Text] [Related]
19. Is routine TORCH screening and urine CMV culture warranted in small for gestational age neonates?
van der Weiden S; de Jong EP; Te Pas AB; Middeldorp JM; Vossen AC; Rijken M; Walther FJ; Lopriore E
Early Hum Dev; 2011 Feb; 87(2):103-7. PubMed ID: 21145674
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of a cytomegalovirus screening strategy in neonates born after 34 weeks small for gestational age.
Merino-Hernández A; Sánchez-Barriopedro L; Villar-Castro S; Aguado-Del Hoyo A; Marsinyach-Ros I; Sánchez-Luna M
An Pediatr (Engl Ed); 2023 Jan; 98(1):41-47. PubMed ID: 36528494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
